CAGR of 6.4 %, Atrial Fibrillation Market Revenue to Cross USD 3,370.70 million by 2030 - Allied Market Research

North America is the largest market for AFib treatments, with a high prevalence of AFib and a well-developed healthcare infrastructure

Atrial fibrillation market size was valued at $1,825.85 million in 2020, and is projected to reach $3,370.70 million by 2030, growing at a CAGR of 6.4% from 2021 to 2030. Atrial fibrillation is the most common arrhythmia and occurs when the heart's upper chambers (atria) receive erratic electrical impulses. As a result, the beat becomes fast and uneven. Atrial fibrillation can cause heart rate of 100 to 175 beats per minute. Confusion, dizziness, exhaustion, and fainting are the symptoms of atrial fibrillation.

The Atrial Fibrillation market is experiencing growth due to a number of factors, including the rise in occurrences of the condition in the aging population, advancements in technology, and a growing preference for catheter ablation as a treatment for cardiac arrhythmias. However, the market may be limited by a shortage of experienced professionals and a preference for pharmaceutical treatments over AF therapy devices. In addition, the emergence of biotech and genetic-based therapies is expected to increase demand for drugs, reducing the need for AF devices. The combination of medication and devices has also been shown to produce better outcomes in the treatment of cardiac arrhythmias, further contributing to the expansion of the Atrial Fibrillation market during the forecast period.

Catheter ablation is a minimally invasive procedure used to treat irregular heartbeats when medication is ineffective. It works by removing the damaged tissue in the heart that causes the arrhythmias, and has a very high success rate of 95%. This method is becoming increasingly popular due to its low risk and high efficacy.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐀𝐭𝐫𝐢𝐚𝐥 𝐅𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.alliedmarketresearch.com/request-sample/479

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

𝐉𝐨𝐡𝐧𝐬𝐨𝐧 & 𝐉𝐨𝐡𝐧𝐬𝐨𝐧, 𝐌𝐢𝐜𝐫𝐨𝐏𝐨𝐫𝐭 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧, 𝐁𝐨𝐬𝐭𝐨𝐧 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧, 𝐬𝐭. 𝐣𝐮𝐝𝐞 𝐦𝐞𝐝𝐢𝐜𝐚𝐥, 𝐌𝐞𝐝𝐭𝐫𝐨𝐧𝐢𝐜 𝐩𝐥𝐜, 𝐀𝐛𝐛𝐨𝐭𝐭 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬, 𝐁𝐢𝐨𝐭𝐫𝐨𝐧𝐢𝐤 𝐒𝐄 & 𝐂𝐨. 𝐊𝐆, 𝐊𝐨𝐧𝐢𝐧𝐤𝐥𝐢𝐣𝐤𝐞 𝐏𝐡𝐢𝐥𝐢𝐩𝐬 𝐍.𝐕., 𝐒𝐢𝐞𝐦𝐞𝐧𝐬 𝐀𝐆, 𝐀𝐭𝐫𝐢𝐂𝐮𝐫𝐞 𝐈𝐧𝐜

Leading healthcare and medical device companies are investing in advanced catheter ablation technology to treat atrial fibrillation and reduce the risk of stroke in patients. For example, Abbott Laboratories recently introduced the TactiFlex PAF IDE ablation catheter, which is specifically designed for patients with symptoms of atrial fibrillation that cannot be treated with medication. The catheter is equipped with sensors to accurately locate and treat the source of the irregular heartbeat.

In 2020, the atrial fibrillation market generated the highest revenue in North America, due to a number of factors. One of the key drivers is the widespread adoption of technologically advanced devices for the treatment of atrial fibrillation in North American countries. Additionally, the rapid increase in cardiac diseases among the aging population presents a significant challenge for healthcare systems, leading to a greater demand for new and innovative products to treat atrial fibrillation. This demand, combined with the high rate of technological advancement in the region, has driven growth in the atrial fibrillation market in North America.

𝐓𝐡𝐞 𝐚𝐭𝐫𝐢𝐚𝐥 𝐟𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐜𝐚𝐭𝐞𝐠𝐨𝐫𝐢𝐞𝐬 𝐭𝐨 𝐩𝐫𝐨𝐯𝐢𝐝𝐞 𝐚 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬. 𝐓𝐡𝐞𝐬𝐞 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

Type: This segment is divided into surgical and non-surgical treatments for atrial fibrillation.

Technology: This segment is divided into radiofrequency, laser, cryotherapy, and others.

End user: The market is segmented into hospitals, specialty clinics, and others.

Geography: The market analysis is conducted across four regions: North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/connect-to-analyst/479

𝐀𝐭𝐫𝐢𝐚𝐥 𝐅𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐢𝐧 𝐃𝐞𝐭𝐚𝐢𝐥:

By Type:

Surgical: This segment of the atrial fibrillation market includes surgical procedures such as maze surgery and surgical ablation for the treatment of AFib. The demand for surgical treatments is expected to decline as non-surgical methods become increasingly popular due to their low invasiveness and high success rates.

Non-Surgical: This segment of the atrial fibrillation market includes non-surgical methods such as catheter ablation, electrical cardioversion, and medication management. Non-surgical methods have a higher success rate and are less invasive than surgical methods, making them more popular among patients and healthcare providers.

By Technology:

Radiofrequency: This technology uses radiofrequency energy to destroy the heart tissue that causes AFib. This is a popular technology for non-surgical treatments of AFib and is widely used due to its high success rates.

Laser: This technology uses laser energy to destroy the heart tissue that causes AFib. It is a newer technology that is becoming more popular due to its precise targeting and low invasiveness.

Cryotherapy: This technology uses extremely cold temperatures to destroy the heart tissue that causes AFib. It is a newer technology that is becoming more popular due to its precise targeting and low invasiveness.

Others: This segment of the atrial fibrillation market includes other technologies such as ultrasound and microwave energy that are used for the treatment of AFib.

By End User:

Hospitals: Hospitals are the largest end-users of AFib treatments, as they provide a full range of diagnostic and therapeutic services for AFib patients.

Specialty Clinics: Specialty clinics are becoming increasingly popular for AFib treatments, as they provide specialized services for AFib patients and offer more personalized care.

Others: This segment of the atrial fibrillation market includes other end-users such as research institutions and home healthcare providers.

By Region:

North America: North America is the largest market for AFib treatments, with a high prevalence of AFib and a well-developed healthcare infrastructure.

Europe: Europe is the second-largest market for AFib treatments, with a high prevalence of AFib and a well-developed healthcare infrastructure.

Asia-Pacific: Asia-Pacific is the fastest-growing market for AFib treatments, with a growing aging population and an increasing demand for AFib treatments.

LAMEA: LAMEA is a growing market for AFib treatments, with a growing aging population and an increasing demand for AFib treatments.

𝐐𝐮𝐢𝐜𝐤𝐥𝐲 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐀𝐭𝐫𝐢𝐚𝐥 𝐅𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.alliedmarketresearch.com/checkout-final/f16088da7907ab0f8431aa7f585b4cb2

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Website: www.alliedmarketresearch.com

This release was published on openPR.